323 related articles for article (PubMed ID: 7512010)
1. B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).
Sfikakis PP; Oglesby R; Sfikakis P; Tsokos GC
Clin Exp Immunol; 1994 Apr; 96(1):8-14. PubMed ID: 7512010
[TBL] [Abstract][Full Text] [Related]
2. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M
Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537
[TBL] [Abstract][Full Text] [Related]
3. Defective antigen-presenting cell function in patients with systemic lupus erythematosus.
Tsokos GC; Kovacs B; Sfikakis PP; Theocharis S; Vogelgesang S; Via CS
Arthritis Rheum; 1996 Apr; 39(4):600-9. PubMed ID: 8630108
[TBL] [Abstract][Full Text] [Related]
4. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
Koulova L; Clark EA; Shu G; Dupont B
J Exp Med; 1991 Mar; 173(3):759-62. PubMed ID: 1847724
[TBL] [Abstract][Full Text] [Related]
5. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
Ranheim EA; Kipps TJ
J Exp Med; 1993 Apr; 177(4):925-35. PubMed ID: 7681471
[TBL] [Abstract][Full Text] [Related]
6. Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin diseases.
Simon JC; Dietrich A; Mielke V; Wuttig C; Vanscheidt W; Linsley PS; Schöpf E; Sterry W
J Invest Dermatol; 1994 Oct; 103(4):539-43. PubMed ID: 7523532
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 and B7/CD28 interaction regulate interleukin-6 production by human T cells.
Lorré K; Kasran A; Van Vaeck F; de Boer M; Ceuppens JL
Clin Immunol Immunopathol; 1994 Jan; 70(1):81-90. PubMed ID: 7505212
[TBL] [Abstract][Full Text] [Related]
8. Accessory signalling by B7-1 for T cell activation induced by anti-CD2: evidence for IL-2-independent CTL generation and CsA-resistant cytokine production.
Van Gool SW; Kasran A; Wallays G; de Boer M; Ceuppens JL
Scand J Immunol; 1995 Jan; 41(1):23-30. PubMed ID: 7529939
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of interleukin-2 and apha-chain interleukin-2 receptor biosynthesis by cisplatin in human peripheral lymphocytes.
Sfikakis PP; Souliotis VL; Katsilambros N; Markakis K; Vaiopoulos G; Tsokos GC; Panayiotidis P
Clin Immunol Immunopathol; 1996 Apr; 79(1):43-9. PubMed ID: 8612350
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
[TBL] [Abstract][Full Text] [Related]
11. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
[TBL] [Abstract][Full Text] [Related]
12. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
Behar SM; Porcelli SA; Beckman EM; Brenner MB
J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.
Kubin M; Kamoun M; Trinchieri G
J Exp Med; 1994 Jul; 180(1):211-22. PubMed ID: 7516408
[TBL] [Abstract][Full Text] [Related]
14. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
15. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel MF; Allison JP
J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
[TBL] [Abstract][Full Text] [Related]
16. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
Murphy EE; Terres G; Macatonia SE; Hsieh CS; Mattson J; Lanier L; Wysocka M; Trinchieri G; Murphy K; O'Garra A
J Exp Med; 1994 Jul; 180(1):223-31. PubMed ID: 7516409
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction by B7/BB1 expressed on activated T lymphocytes: cross-linking of B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T-cell receptor/CD3.
Hirokawa M; Kitabayashi A; Kuroki J; Miura AB
Immunology; 1995 Oct; 86(2):155-61. PubMed ID: 7490112
[TBL] [Abstract][Full Text] [Related]
18. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.
Ramarathinam L; Castle M; Wu Y; Liu Y
J Exp Med; 1994 Apr; 179(4):1205-14. PubMed ID: 7511683
[TBL] [Abstract][Full Text] [Related]
19. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
Ding L; Shevach EM
Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
[TBL] [Abstract][Full Text] [Related]
20. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.
Van Gool SW; de Boer M; Ceuppens JL
J Immunol; 1993 Apr; 150(8 Pt 1):3254-63. PubMed ID: 7682237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
